The year in cardiology: cardiovascular prevention. The year in cardiology 2019

While imaging is clearly important its use is likely to be useful after decades of exposure to risk factors and still provides assessment for short-to intermediate-term risk.Recently, a lifetime-perspective CardioVascular Disease (LIFE-CVD) model for the estimation of treatment-effects of cholesterol-lowering, blood pressure lowering, antithrombotic therapy, and smoking cessation in apparently healthy people has been developed.This freely accessible online calculator (www.U-Prevent.com)estimates risk and treatment effects in terms of improved 10year risk, lifetime risk, and life-expectancy free of CVD and is designed to facilitate doctor-patient communication.(6) Large trials of pharmacological intervention assessing outcomes over CARDIO-VASCULAR PREVENTION

Abstract licence: CC BY-NC-ND

1. 40.

   Long-term and recent trends in hypertension awareness, treatment, and control in 12 high-income countries: an analysis of 123 nationally representative surveys · 2019

39 more references, whose wording the paper’s licence keeps private.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.